[PDF][PDF] Prioritization of therapeutic targets and trial design in cirrhotic portal hypertension

JG Abraldes, J Trebicka, N Chalasani, G D'Amico… - …, 2019 - Wiley Online Library
Portal hypertension (PH) is the main driver of cirrhosis decompensation, the main
determinant of death in patients with cirrhosis. PH results initially from increased intrahepatic …

[PDF][PDF] Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension.

JG Abraldes, J Trebicka, N Chalasani, G D'Amico… - Hepatology, 2019 - boris.unibe.ch
Portal hypertension is the main driver of cirrhosis decompensation, the main determinant of
death in patients with cirrhosis. Portal hypertension results initially from increased …

Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension

JG Abraldes, J Trebicka… - Hepatology …, 2019 - pubmed.ncbi.nlm.nih.gov
Portal hypertension (PH) is the main driver of cirrhosis decompensation, the main
determinant of death in patients with cirrhosis. PH results initially from increased intrahepatic …

[PDF][PDF] Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension

JG Abraldes, J Trebicka, N Chalasani, G D'Amico… - scholarworks.indianapolis.iu.edu
Portal hypertension is the main driver of cirrhosis decompensation, the main determinant of
death in patients with cirrhosis. Portal hypertension results initially from increased …

Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension

JG Abraldes, J Trebicka, N Chalasani… - …, 2019 - mayoclinic.elsevierpure.com
Portal hypertension (PH) is the main driver of cirrhosis decompensation, the main
determinant of death in patients with cirrhosis. PH results initially from increased intrahepatic …

[PDF][PDF] Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension

JG Abraldes, J Trebicka, N Chalasani, G D'Amico… - 2019 - scholarworks.iupui.edu
Portal hypertension (PH) is the main driver of cirrhosis decompensation, the main
determinant of death in patients with cirrhosis. PH results initially from increased intrahepatic …

[PDF][PDF] Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension

JG Abraldes, J Trebicka, N Chalasani, G D'Amico… - core.ac.uk
Portal hypertension is the main driver of cirrhosis decompensation, the main determinant of
death in patients with cirrhosis. Portal hypertension results initially from increased …

Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension.

JG Abraldes, J Trebicka, N Chalasani… - Hepatology (Baltimore …, 2019 - folia.unifr.ch
English Portal hypertension (PH) is the main driver of cirrhosis decompensation, the main
determinant of death in patients with cirrhosis. PH results initially from increased intrahepatic …

Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension.

JG Abraldes, J Trebicka, N Chalasani… - Hepatology (Baltimore …, 2019 - sonar.ch
English Portal hypertension (PH) is the main driver of cirrhosis decompensation, the main
determinant of death in patients with cirrhosis. PH results initially from increased intrahepatic …

[HTML][HTML] Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension

JG Abraldes, J Trebicka, N Chalasani… - Hepatology …, 2019 - ncbi.nlm.nih.gov
Portal hypertension (PH) is the main driver of cirrhosis decompensation, the main
determinant of death in patients with cirrhosis. PH results initially from increased intrahepatic …